Bio-Thera Solutions

Beijiang, Beijing Municipality

OncologyantibodyFiled/Approved

What changed

Phase II trial registered: Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema

1w agoTrial registeredJul 14, 2026Source filing (opens the source filing in a new tab)

Momentum

100no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Filed/Approved

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

102 pre-ticker oncology companies at Filed/Approved

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
PHASE3 registered
May 1, 2026
Locally Advanced Rectal Cancer (LARC), MSS (Microsatellite Stable) · NOT_YET_RECRUITING · sponsor: Fudan University · SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer
ClinicalTrials.gov · NCT07551479 (opens the source filing in a new tab)
Trial
Study registered
Sep 18, 2025
Severe Pneumonia · ACTIVE_NOT_RECRUITING · sponsor: Guangzhou Medical University · AI-Driven Accurate Diagnosis of Pathogens in Severe Pneumonia
ClinicalTrials.gov · NCT07461714 (opens the source filing in a new tab)
Trial
PHASE2 registered
Mar 10, 2025
Locally Recurrent Rectal Cancer · RECRUITING · sponsor: Fudan University · Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
ClinicalTrials.gov · NCT06928584 (opens the source filing in a new tab)
Trial
PHASE2 registered
Aug 13, 2024
Locally Advanced Rectal Cancer · RECRUITING · sponsor: Fudan University · MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
ClinicalTrials.gov · NCT06840665 (opens the source filing in a new tab)
Trial
PHASE2 registered
Jul 1, 2024
Stomach Adenocarcinoma, Gastro-esophageal Junction Cancer · SUSPENDED · sponsor: Fudan University · Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma
ClinicalTrials.gov · NCT06728657 (opens the source filing in a new tab)
Trial
PHASE2 registered
Apr 1, 2024
Anal Squamous Cell Cancer · RECRUITING · sponsor: Fudan University · Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase
ClinicalTrials.gov · NCT07555678 (opens the source filing in a new tab)
Trial
Study registered
Sep 1, 2023
Breast Cancer Female, Endocrine Therapy · RECRUITING · sponsor: Hongmei Zheng, PhD · The Benefits of Continued Use of Ovarian Function Suppression After 5 Years
ClinicalTrials.gov · NCT06050109 (opens the source filing in a new tab)
Trial
PHASE4 registered
Jun 1, 2023
Sepsis, Ivabradine, Hemodynamics, Heart Rate Control · RECRUITING · sponsor: Second Affiliated Hospital of Guangzhou Medical University · Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis
ClinicalTrials.gov · NCT05882708 (opens the source filing in a new tab)
Trial
PHASE2 registered
Dec 12, 2022
Early Low Rectal Cancer · RECRUITING · sponsor: Fudan University · The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer
ClinicalTrials.gov · NCT05555888 (opens the source filing in a new tab)
Trial
PHASE3 registered
Jul 7, 2022
Neovascular (Wet) Age-related Macular Degeneration · COMPLETED · sponsor: Bio-Thera Solutions · Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration
ClinicalTrials.gov · NCT05439629 (opens the source filing in a new tab)
Trial
PHASE1/PHASE2 registered
Oct 16, 2020
Diabetic Macular Edema · COMPLETED · sponsor: Bio-Thera Solutions · Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema
ClinicalTrials.gov · NCT04772105 (opens the source filing in a new tab)
Trial
PHASE3 registered
Dec 1, 2016
Stomach Neoplasm, GastroEsophageal Cancer, Adenocarcinoma, Locally Advanced Cancer, Chemoradiation · COMPLETED · sponsor: Shanghai Cancer Hospital, China · PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy
ClinicalTrials.gov · NCT03013010 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.93name similarity 100% · shared principal investigator / founder
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the trial record at 0.50name similarity 100%

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Phase II trial registered: Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema
1w agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema
1w agoTrial completedSource (opens the source filing in a new tab)
Phase II trial registered: Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase
2mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase
2mo agoTrial recruitingSource (opens the source filing in a new tab)
Phase III trial registered: SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer
2mo agoTrial registeredSource (opens the source filing in a new tab)
Filed/Approved trial registered: Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis
2mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis
2mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: AI-Driven Accurate Diagnosis of Pathogens in Severe Pneumonia
4mo agoTrial registeredSource (opens the source filing in a new tab)
Phase III trial registered: Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration
7mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration
7mo agoTrial completedSource (opens the source filing in a new tab)
Phase III trial registered: PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy
7mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy
7mo agoTrial completedSource (opens the source filing in a new tab)
Phase II trial registered: Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma
Jun 2025Trial registeredSource (opens the source filing in a new tab)
Phase II trial registered: Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
Apr 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
Apr 2025Trial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: The Benefits of Continued Use of Ovarian Function Suppression After 5 Years
Mar 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: The Benefits of Continued Use of Ovarian Function Suppression After 5 Years
Mar 2025Trial recruitingSource (opens the source filing in a new tab)
Phase II trial registered: MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
Feb 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
Feb 2025Trial recruitingSource (opens the source filing in a new tab)
Phase II trial registered: The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer
Jan 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer
Jan 2025Trial recruitingSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

PHASE3 registered

Study registered

PHASE2 registered

PHASE2 registered

PHASE2 registered

PHASE2 registered

Study registered

PHASE4 registered

PHASE2 registered

PHASE3 registered

PHASE1/PHASE2 registered

PHASE3 registered